Gruninger Marc () bought 10,000 shares at an average price of $0.9983 per common share. (Date: 2026-10-28)
Gruninger Marc () bought 10,000 shares at an average price of $0.9983 per common share. (Date: 2026-10-28)
https://insiderbid.com/insider/0002128575
https://insiderbid.com/insider/0002128575
• Insider: Marc Gruninger, Director
• Bought: 10,000 shares (about $10K)
• Price: about $1.00 a share · Oct 27-28
• Filed: Oct 29 · Form 4
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
• Insider: Marc Gruninger, Director
• Bought: 10,000 shares (about $10K)
• Price: about $1.00 a share · Oct 27-28
• Filed: Oct 29 · Form 4
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
https://yarako.com/insider-buying/VRXA
Data from SEC Form 4 filings. For information only. Not investment advice. Past insider purchases do not predict future returns.
https://yarako.com/insider-buying/VRXA
Data from SEC Form 4 filings. For information only. Not investment advice. Past insider purchases do not predict future returns.
Director Christoph Samuel Ziegler bought $32,700 of shares on 20 Oct (SEC filing, 21 Oct).
Holding ×4.8
Every real insider buy, noise removed: chalni.com
#insiderbuying #stocks
Director Christoph Samuel Ziegler bought $32,700 of shares on 20 Oct (SEC filing, 21 Oct).
Holding ×4.8
Every real insider buy, noise removed: chalni.com
#insiderbuying #stocks
https://insiderbid.com/insider/0002123272
https://insiderbid.com/insider/0002123272
• Insider: Christoph Samuel Ziegler, Director
• Bought: 30,000 shares (about $33K)
• Price: about $1.09 a share · Oct 20
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
• Insider: Christoph Samuel Ziegler, Director
• Bought: 30,000 shares (about $33K)
• Price: about $1.09 a share · Oct 20
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#InsiderBuying #Stocks
m.youtube.com/watch?v=vrxA...
m.youtube.com/watch?v=vrxA...
https://www.stocktitan.net/news/VRXA/veraxa-biotech-presents-in-vivo-proof-of-concept-data-for-bi-tac-adc-e978as89c9du.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/VRXA/veraxa-biotech-presents-in-vivo-proof-of-concept-data-for-bi-tac-adc-e978as89c9du.html?utm_source=stocktitan-bluesky&utm_medium=social